EXPANDED INDICATION IN EU
FOR ORAL REVLIMID

 

 

 

 

Now Approved for the treatment of Adult Patients
with Previously Untreated Multiple Myeloma
who are Not Eligible for Transplant.

 

 

 

 

 

Celgene Treatments

Learn more about our portfolio of treatment and services